Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11303120 | 0.89 | MEN1 (0.77) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL12418543 | 0.88 | MEN1 (0.58) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL11369449 | 0.87 | KMT2A (0.79) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL12394779 | 0.82 | MEN1 (0.76) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL10364639 | 0.82 | MEN1 (0.57) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL12418677 | 0.81 | MEN1 (0.74) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL1964298 | 0.81 | MEN1 (0.57) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL12418678 | 0.81 | MEN1 (0.56) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL13447835 | 0.81 | MEN1 (0.56) | KMT2AMEN1TDP1HSP90AA1CYP19A1 | |
| SCHEMBL8927137 | 0.79 | MEN1 (0.52) | KMT2AMEN1TDP1HSP90AA1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172098-A1 | Imidazole and Triazole Compounds, Their Use and Agents Containing the Same | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| US-20110172098-A1 | Imidazole and Triazole Compounds, Their Use and Agents Containing the Same | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172098-A1 | Imidazole and Triazole Compounds, Their Use and Agents Containing the Same | COX4I1, CYP2C19, CYP3A43 | KMT2A 1323/4885MEN1 986/4885TDP1 688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.